Report me for selling fake medicine? Why are you crying when your illness relapses?

"Okay, I'll focus on the quality of the building."

"This time we invited several national construction companies, which are also famous for their construction quality."

"Moreover, we have received a deposit of 50 billion yuan from the Medical Insurance Bureau today. Novartis has also promised to pay a deposit of 10 billion US dollars, which will be received tomorrow."

Luo Shiyun reported another latest news.

In order to support the development of Antai Pharmaceutical,

For all the purchase contracts this time, payment is made before delivery, but payment will also be made in installments.

After the first deposit is paid, Antai Pharmaceutical Group will supply the first batch of lung cancer-specific drugs, and then the Medical Insurance Bureau will pay the remaining balance, but it will also be calculated based on the actual supply volume.

For example, if Antai Pharmaceutical Group is going to deliver 100 million boxes of a special lung cancer drug in a period of time, the Medical Insurance Bureau will pay for these 100 million boxes of drugs in advance.

Then, after the next batch of drugs from Antai Pharmaceutical Group is ready, the payment for the next batch will be paid in advance.

……

……

Chen Xuan was very satisfied with this deposit.

In other words, these two deposits were also the first revenue generated by Antai Pharmaceutical Group.

Previously, Antai Pharmaceutical Group had no income, but now it has finally started to generate real revenue.

Moreover, not only can it generate income, the profits are also astonishing, which can be regarded as shocking profits.

"If R&D expenses are not included,"

"At the current production scale, the total cost of producing a box of lung cancer medicine is 100 yuan. The overseas version is a bit higher, around 120 yuan."

"Based on Huaxia's factory price, we make a profit of 1150 yuan per box sold, while based on the factory price in overseas markets, our profit per box is 4880 yuan."

Luo Shiyun smiled and told the production cost of the special medicine for lung cancer.

This total cost includes raw material and wage expenses, equipment depreciation, operating expenses, etc., the total cost of all expenses added together.

There are only two expenses that are not included.

One is R&D expenses.

The second is taxes and fees.

Not to mention the R&D expenses.

This is the cost of the new drug developed personally by Chen Xuan. As for how much R&D expenses are required, it is difficult to calculate.

The R&D costs of other new drugs may cost hundreds of millions of dollars, or may cost $20 billion, $100 billion, or even $10 billion.

However, the actual cost of the various new drugs he developed was very low, and it was mainly due to his experimental expenses. He spent a lot of money this time, but compared with the expenses of other laboratories, it was only a drop in the bucket.

Therefore, Luo Shiyun has no way to calculate the R&D costs for the time being.

As for taxes and fees, there is no need to consider the cost.

Because the ex-factory prices of lung cancer-specific drugs are all tax-exclusive.

In other words, no matter how much tax is paid, it has nothing to do with Antai Pharmaceutical Group, but the buyer will pay the shipping fee.

The reason why the overseas version of the lung cancer specific drug costs more than the lung cancer specific drug is not because the overseas version is more effective or because the quality of the overseas version is different.

The cost is higher mainly due to transportation.

Transporting the products from the production base to various countries requires a lot of transportation costs, and this cost is also borne by Antai Pharmaceutical Group. Only after arriving abroad will Novartis be responsible for the subsequent costs.

Therefore, after taking all these miscellaneous production processes into consideration, the overseas version of the lung cancer drug will be about 20 yuan higher, but the two drugs are exactly the same, only the outer packaging and instructions will be changed to local language, and there is no other difference at all.

Chen Xuan was indeed very satisfied with this profit.

Medicines are indeed more profitable than arms, and it is impossible for arms to achieve such a high profit margin.

Of course, you can choose not to buy medicines, but sometimes you cannot choose not to buy arms. For example, if some countries do not buy American arms, it may be in the news the next day.